9.11
-0.08
(-0.87%)
At close: January 31 at 8:16:34 AM GMT+1
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Cash Flow
-30,812.00
-30,812.00
-27,785.00
-24,238.00
-30,384.00
Financing Cash Flow
11,975.00
11,975.00
29,651.00
21,288.00
153,243.00
End Cash Position
132,187.00
132,187.00
151,024.00
149,158.00
152,108.00
Income Tax Paid Supplemental Data
300.00
300.00
136.00
327.00
140.00
Issuance of Capital Stock
11,284.00
11,284.00
27,875.00
20,985.00
153,219.00
Free Cash Flow
-30,812.00
-30,812.00
-27,785.00
-24,238.00
-30,384.00
9/30/2021 - 4/28/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
19X.SG Axsome Therapeutics Inc
102.25
-2.01%
I9SA.HA Verona Pharma PLC
55.00
+0.92%
TRRI Alzex Neuropharma Inc.
0.1980
0.00%
HALB Halberd Corporation
0.0034
+13.33%
RAPP Rapport Therapeutics, Inc.
16.41
-1.44%
ASND Ascendis Pharma A/S
130.66
+2.64%
NAMS NewAmsterdam Pharma Company N.V.
22.29
+2.39%
PCVX Vaxcyte, Inc.
88.32
-3.95%
DAWN Day One Biopharmaceuticals, Inc.
12.37
-3.81%
IBIO iBio, Inc.
3.0100
+1.35%